Evidence Generation: Evolution and Future of Integrated Evidence Planning

It is increasingly important for the life sciences industry to adopt an integrated approach to planning, generating and managing the evidence required for the value of its innovations. Integrated evidence planning (IEP) is a framework that leverages an ensemble of different data sources, scientific methods and cross-functional expertise across a product’s life cycle to generate key information about its benefits, safety and value most effectively and efficiently.

In this webinar, the expert speaker will provide insights into functional and operational aspects of IEP and the rationale and benefits of IEP. They will discuss the evolution of IEP, future trends and how it meets different stakeholders’ requirements. Attendees will gain insights into the potential barriers to IEP and ways to overcome them, as well as the operational aspects of IEP such as the development, implementation and operationalization of IEP systems.

Join this webinar:

• To understand the rationale for integrated evidence generation and the need for evidence beyond randomized controlled trials
• To learn the evolution of IEP
• To brainstorm on the challenges for IEP and potential solutions to overcome them
• To decipher the architecture of IEP systems and processes involved in their development, implementation and operation
• To form a forward-looking vision with regards to the emerging innovative trends in IEP

Speakers

Won Chan Lee, PhD, Principal and Practice Lead of HEOR/RWE Practice, Axtria – Ingenious Insights

Dr. Won Chan Lee has more than 20 years of experience in health economics and outcomes research, including integrated evidence strategic planning, RWD strategies and RWE studies, economic modeling, post-marketing studies and HRQL/PRO assessments. His research has resulted in more than 55 professional publications in top medical journals and more than 100 presentations at scientific venues, leading to enhanced patient access to health technology. At Axtria, he is Practice Lead of RWE, HEOR and Evidence Synthesis. Prior to Axtria, he had led RWE & HEOR functions at medical device and digital health technology firms and served as a principal consultant at premier consulting companies such as IQVIA, Evidera and Abt Associates. Dr. Lee earned his PhD in Health Economics at the Graduate Center of the City University of New York and his Master’s degree in Economics at the University of Grenoble, France.

Message Presenter

Shibani Pokras, Senior Director and Global Process Owner, Integrated Evidence Planning, GSK

Shibani Pokras is a seasoned leader in evidence strategy and planning, with 10 years of experience at GSK and 10 years of consulting experience in health economics and real world evidence (RWE). She has built new organizational capabilities at GSK and in consulting as Process and Product Owner. As the Global Process Owner of Integrated Evidence Planning at GSK, she is responsible for embedding a new framework for evidence strategy and planning across all therapy areas and lifecycle stages, with the aim of delivering value for patients, payers, physicians and regulators. Shibani and her team have successfully delivered almost 50 integrated evidence planning (IEP) workshops, changing the ways of working of over 1500 employees across global, region, and local evidence generating functions. She led her team to win the prestigious R&D Transformational Medicines & Vaccines Award in 2023 for their impact at GSK. Prior to this Shibani led and executed evidence strategies to address global stakeholder needs and evidence gaps in oncology cell and gene therapy, rare diseases, and maternal and neonatal health.

Message Presenter